These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35106126)

  • 21. HA1-2-fljB Vaccine Induces Immune Responses against Pandemic Swine-Origin H1N1 Influenza Virus in Mice.
    Kang X; Yang Y; Jiao Y; Song H; Song L; Xiong D; Wu L; Pan Z; Jiao X
    J Mol Microbiol Biotechnol; 2016; 26(6):422-432. PubMed ID: 27721310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.
    Weaver EA; Rubrum AM; Webby RJ; Barry MA
    PLoS One; 2011 Mar; 6(3):e18314. PubMed ID: 21464940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal Administration of
    Huynh DT; Chathuranga WAG; Chathuranga K; Lee JS; Kim CJ
    J Microbiol Biotechnol; 2024 Mar; 34(3):735-745. PubMed ID: 37915251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
    Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
    PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.
    Khurana S; Verma S; Verma N; Crevar CJ; Carter DM; Manischewitz J; King LR; Ross TM; Golding H
    J Virol; 2011 Feb; 85(3):1246-56. PubMed ID: 21084473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010-2011 Influenza Seasonal Vaccine.
    Guo Z; Lu X; Carney PJ; Chang J; Tzeng WP; York IA; Levine MZ; Stevens J
    Vaccines (Basel); 2023 Jul; 11(8):. PubMed ID: 37631875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates.
    Xu L; Qin Z; Qiao L; Wen J; Shao H; Wen G; Pan Z
    Vaccine; 2020 Feb; 38(7):1690-1699. PubMed ID: 31937412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1-2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens.
    Song L; Xiong D; Song H; Wu L; Zhang M; Kang X; Pan Z; Jiao X
    Front Immunol; 2017; 8():326. PubMed ID: 28424686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insertion of single-chain variable fragment (scFv) peptide linker improves surface display of influenza hemagglutinin (HA1) on non-recombinant Lactococcus lactis.
    Jee PF; Chen FS; Shu MH; Wong WF; Abdul Rahim R; AbuBakar S; Chang LY
    Biotechnol Prog; 2017 Jan; 33(1):154-162. PubMed ID: 27802566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin Stem Immunogens.
    Kar U; Khaleeq S; Garg P; Bhat M; Reddy P; Vignesh VS; Upadhyaya A; Das M; Chakshusmathi G; Pandey S; Dutta S; Varadarajan R
    Front Immunol; 2022; 13():890622. PubMed ID: 35720346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses.
    Du L; Leung VH; Zhang X; Zhou J; Chen M; He W; Zhang HY; Chan CC; Poon VK; Zhao G; Sun S; Cai L; Zhou Y; Zheng BJ; Jiang S
    PLoS One; 2011 Jan; 6(1):e16555. PubMed ID: 21304591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological studies with the HA1 and HA2 polypeptides of influenza A virus haemagglutinin.
    Kuo YC; Oxford JS; Schild GC
    Exp Cell Biol; 1978; 46(6):338-54. PubMed ID: 81152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of HA1 domain of influenza A/H3N2 viruses isolated in Kenya during the 2007-2013 seasons reveal significant divergence from WHO-recommended vaccine strains.
    Nyang'au EM; Bulimo WD; Mobegi V; Opanda S; Magiri E
    Int J Infect Dis; 2020 Jun; 95():413-420. PubMed ID: 32276045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
    Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection.
    Gocník M; Fislová T; Mucha V; Sládková T; Russ G; Kostolanský F; Varečková E
    J Gen Virol; 2008 Apr; 89(Pt 4):958-967. PubMed ID: 18343837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualization of Alternative Functional Configurations of Influenza Virus Hemagglutinin Facilitates Rapid Selection of Complementing Vaccines in Emergency Situations.
    Metwally A; Yousif A
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.
    Durviaux S; Treanor J; Beran J; Duval X; Esen M; Feldman G; Frey SE; Launay O; Leroux-Roels G; McElhaney JE; Nowakowski A; Ruiz-Palacios GM; van Essen GA; Oostvogels L; Devaster JM; Walravens K
    Clin Vaccine Immunol; 2014 Mar; 21(3):271-9. PubMed ID: 24371255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.
    Xu L; Bao L; Lau SY; Wu WL; Yuan J; Gu S; Li F; Lv Q; Xu Y; Pushko P; Chen H; Qin C
    Vaccine; 2016 May; 34(23):2627-33. PubMed ID: 27083426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.